The influence of heparin's molecular weight and the incidence of delayed type hypersensitivity reactions revisited; In response to Grims et al., Br J Dermatol 2007; 157:514-17

British Journal of Dermatology

Volumn 158, Issue 4, 2008, Pages 849-851

  Ludwig, R J ^a,b   Schindewolf, M ^a   Lindhoff Last, E ^a   Boehncke, W H ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Allergy; Delayed type hypersensitivity (DTH); Heparin; Molecular weight; Skin

Indexed keywords

BEMIPARIN; CERTOPARIN; DALTEPARIN; DANAPAROID; ENOXAPARIN; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; PENTOSAN POLYSULFATE; REVIPARIN; TINZAPARIN;

ALLERGY TEST; DELAYED HYPERSENSITIVITY; DRUG TOLERABILITY; HUMAN; IMMUNOLOGY; LETTER; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROPHYLAXIS; SKIN DEFECT; THROMBOCYTOPENIA; THROMBOEMBOLISM;

ANTICOAGULANTS; CROSS REACTIONS; DRUG ERUPTIONS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; HYPERSENSITIVITY, DELAYED;

EID: 40949165725     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.08402.x     Document Type: Letter

References (10)

1. Warkentin TE, Roberts RS, Hirsh J et al. Heparin-induced skin lesions and other unusual sequelae of the heparin-induced thrombocytopenia syndrome: a nested cohort study. Chest 2005 127 : 1857 61.
2. Boehncke WH, Weber L, Gall H. Tolerance to intravenous administration of heparin and heparinoid in a patient with delayed-type hypersensitivity to heparins and heparinoids. Contact Dermatitis 1996 35 : 73 5.
3. Ludwig RJ, Schindewolf M, Utikal J et al. Management of cutaneous type IV hypersensitivity reactions induced by heparin. Thromb Haemost 2006 96 : 611 17.
4. Bircher AJ, Harr T, Hohenstein L et al. Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options. Allergy 2006 61 : 1432 40.
5. Grims RH, Weger W, Reiter H et al. Delayed-type hypersensitivity to low molecular weight heparins and heparinoids: cross-reactivity does not depend on molecular weight. Br J Dermatol 2007 157 : 514 17.
6. Ludwig RJ, Schindewolf M, Alban S et al. Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides. Thromb Haemost 2005 94 : 1265 9.
7. Hirsch K, Ludwig RJ, Lindhoff-Last E et al. Intolerance of fondaparinux in a patient allergic to heparins. Contact Dermatitis 2004 50 : 383 4.
8. Maetzke J, Hinrichs R, Schneider LA et al. Unexpected delayed-type hypersensitivity skin reactions to the ultra-low-molecular-weight heparin fondaparinux. Allergy 2005 60 : 413 15.
9. Hohenstein E, Tsakiris D, Bircher AJ. Delayed-type hypersensitivity to the ultra-low-molecular-weight heparin fondaparinux. Contact Dermatitis 2004 51 : 149 51.
10. Ludwig RJ, Alban S, Boehncke WH. Structural requirements of heparin and related molecules to exert a multitude of anti-inflammatory activities. Mini Rev Med Chem 2006 6 : 1009 23.